Blackstone and Ferring pump $570m into bladder cancer gene therapy
Decision followed a successful appeal by manufacturer.
NICE lifts restrictions on Ferring prostate cancer drug
Manchester will lead the way towards integrated care
Manchester’s devolution revolution: will pharma get a seat at the table?